Austrian information center regarding clinical trials for cancer therapy
The National Cancer Clinical Trials Helpdesk has added an information service to the European database.
Participation in a clinical cancer study should thus be considerably facilitated. The information is aimed primarily at medical professionals. Patients should only look for a suitable study together with their attending physicians.
The basic principle of the contact point is that every inquiry is answered comprehensively and promptly by qualified physicians at Gesundheit Österreich GmbH. This means independent, objective and competent information about ongoing clinical trials.
Range of tasks of the enquiry unit:
- Support for online search in the EU Clinical Trials Register
- Information on ongoing clinical trials
- Further research on clinical studies
- Mediation of contacts to study contact persons
The helpdesk is set up as a one-year pilot project which is in the process of being set up. Accordingly, the range of tasks will evolve according to the information needs.
Contact the enquiry unit:
The enquiry unit can only be contacted by e-mail.
E-mail address: email@example.com
Each request will be answered as soon as possible. Depending on the scope of the search, this may take several days.
How to find a suitable clinical trial?
The clinical trials can be found in the freely accessible EU Clinical Trials Register. The register shall be kept in the English language. It contains records of officially approved drug trials in Europe. The result of the search provides information about the location and current status of the study.
Guidance and examples for searching the EU CTR database for clinical trials
Which studies can be found in the database?
The register contains records of officially approved drug trials in Europe. In Austria, there has for many years been a central licensing requirement for clinical drug trials. The data records of the clinical trials approved in Austria will be included in the EU Clinical Trials Register.
Clinical trials and cancer framework programme
A goal anchored in the Austrian Cancer Framework Programme is to promote the early participation of cancer patients in appropriate clinical trials, regardless of their place of residence and socio-economic situation. This requires information about the clinical drug trials approved in Austria for physicians and patients.
The national cancer framework programme provides an overview of the most important fields of action in oncology. It was prepared under the auspices of the Federal Ministry of Health, with all relevant institutions and organisations preparing an analysis of the current situation. On this basis, the Oncology Advisory Board defined corresponding goals, measures and metrics in the areas of prevention, diagnostics, treatment, research, psycho-oncology, palliative and hospice care, oncological rehabilitation and epidemiology.
National Cancer Framework Programme (PDF 1967 KB)
Safety for patients
New drugs must be tested for efficacy, side effects and safety in clinical trials before they can be approved. The spectrum of clinical drug trials ranges from the first application of new substances in humans to the collection of long-term data on the safety of already approved preparations. Innovative therapies can increase the chances of cure, while "patient safety" is guaranteed by strict approval procedures and constant monitoring. Through their participation, the study participants in turn contribute to more effective drugs being tested in the light of the latest scientific findings and then used.
What are the advantages of participating in a study?
Clinical studies represent the decisive interface between innovative cancer research and successful therapy. They provide patients with direct access to the latest therapeutic developments and thus offer the opportunity to benefit directly and promptly from current research results. Participants in clinical trials receive very intensive and individual care. As a rule, clinical studies are conducted in university hospitals, cancer centers, etc., which have extensive experience in the treatment of cancer.